Elsevier

Brain Research

Volume 276, Issue 2, 16 October 1983, Pages 231-235
Brain Research

Characterization and regional distribution of serotonin S2-receptors in human brain

https://doi.org/10.1016/0006-8993(83)90729-1Get rights and content

Abstract

[3H]Ketanserin binding was characterized in vitro in human brain homogenates and the regional distribution of the sites was determined.

In human brain, [3H]ketanserin was found to bind on serotonin (5-HT) S2-receptors; only 5-HT antagonists competed with the labelled ligand at nanomolar concentrations; other drugs were much less active or inactive. Special attention was paid to the choice of a displacer, here methysergide, to determine the blank value (non-displaceable binding). [3H]Ketanserin binding in human brain displayed similar binding characteristics to the S2-receptor in the rat frontal cortex, high affinity (Kd 0.69 nM) and relatively slow dissociation rate.

The regional distribution of serotonin S2-receptors labelled with [3H]ketanserin was studied in 30 different regions of human brain. The highest number of receptors was measured in the cortex. However, within the cortex the distribution was also inhomogeneous, a much lower number of sites being found in the pre- and post-central gyri. In the dopaminergic areas and the cerebellum the number of sites was quite low, and only few binding sites were detected in the corpus callosum, the medulla and the hypophysis.

The large number of serotonin S2-receptors in the human cortex suggests that serotonin has an important role in this brain region.

Cited by (126)

  • Serotonin 2A receptors and cannabinoids

    2021, Progress in Brain Research
    Citation Excerpt :

    The study of the anatomical distribution of 5-HT2ARs in the CNS is essential to elucidate the brain regions implicated in the regulation of the different mental processes in which this receptor is involved. In this context, 5-HT2ARs are abundantly expressed in several brain cortical areas, as originally outlined by studies using receptor radioligand binding approaches with human brain tissue homogenates (Schotte et al., 1983). A posterior study in postmortem human brain sections demonstrated that 5-HT2ARs are especially present in cortical layers III and V, hypothalamus and, to a lesser extent, in the hippocampus and striatal structures (Pazos et al., 1987).

  • Assessment of serotonin release capacity in the human brain using dexfenfluramine challenge and [ <sup>18</sup>F]altanserin positron emission tomography

    2012, NeuroImage
    Citation Excerpt :

    Post hoc test revealed that especially the 60 mg dose significantly reduced BPP measures (Fig. 6). It should be noted that BPP might underestimate the true treatment effect, given that the cerebellum still has ~ 15% of the 5-HT2AR receptor density of the PFC (Eastwood et al., 2001; Luabeya et al., 1984; Pazos et al., 1987; Schotte et al., 1983). Cerebellar 5-HT2ARs might be comparably susceptible to dexfenfluramine-induced 5-HT efflux (or internalization) as cortical 5-HT2ARs.

  • Antipsychotic drug interactions with specific [<sup>3</sup>H]ketanserin binding sites in membrane fragments derived from human prefrontal cortex and human amygdala

    2003, Brain Research
    Citation Excerpt :

    The possibility of a third affinity state for [3H]ketanserin in prefrontal cortex is also suggested by the fact that adrenergic agonists compete for less than 70% of the binding present in this region, but all of the binding present in amygdala. Multiple affinity states for [3H]ketanserin have been previously reported in human brain, rodent brain, and human platelets [9,12,13,18,19,26], although single affinity states have also been reported in these same tissues [8,12,14,16,18,21,28]. The previous studies of human amygdala have shown a single affinity state for [3H]ketanserin [8,14].

View all citing articles on Scopus
View full text